WO1995002635A1 - Latex fluorescent comportant au moins deux fluorochromes, procede d'obtention et application - Google Patents
Latex fluorescent comportant au moins deux fluorochromes, procede d'obtention et application Download PDFInfo
- Publication number
- WO1995002635A1 WO1995002635A1 PCT/FR1994/000867 FR9400867W WO9502635A1 WO 1995002635 A1 WO1995002635 A1 WO 1995002635A1 FR 9400867 W FR9400867 W FR 9400867W WO 9502635 A1 WO9502635 A1 WO 9502635A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bpea
- particles
- fluorochrome
- fluorescent latex
- latex according
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
- C08K5/0041—Optical brightening agents, organic pigments
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K9/00—Use of pretreated ingredients
- C08K9/10—Encapsulated ingredients
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/80—Fluorescent dyes, e.g. rhodamine
Definitions
- the present invention relates to a fluorescent latex, the particles of which contain encapsulated with at least two hydrophobic fluorochromes. It also relates to a process for the preparation of said latex and the application thereof as a marker, in particular in biology.
- Latexes are aqueous dispersions of polymer particles, the size of which is generally between 0.05 microns and several microns. Given their particulate appearance, latexes offer a large specific surface which is advantageously exploited in a large number of applications and in particular in the paper, paint, magnetic tape, recording and biology industries.
- the advantages of fluorescent labeling, compared to radioactive labeling, are manifold.
- the risk of radioactive exposure is zero.
- the fluorescent marking has excellent stability over time and above all it provides a more refined response due to the specificity of the fluorescence emission at certain environmental parameters. Its use therefore does not require the implementation of post-analysis separations.
- Fluorescence resulting from simple molecular grafting, has insufficient sensitivity for generalized practical application. It is difficult to detect it when the concentration of the entities present in the medium is less than 10-9 mole / liter. This considerably limits the use of this technique.
- the sensitivity of fluorescence should be comparable to that of radioactive labeling, which implies being able to work at concentrations between 10-12 and 10-15 moles of particles per liter.
- the medium in which the compounds to be assayed are present can interfere with the fluorescence emitted by the fluorochromes (for example Rayleigh, Raman diffusion of water).
- fluorochromes for example Rayleigh, Raman diffusion of water.
- the fluorescence analysis signal is located above 500 nanometers with the widest spectral difference between excitation and emission.
- the present invention specifically aims to overcome these drawbacks and / or to solve the problems indicated above.
- the invention relates to a fluorescent latex, the particles of which encapsulated contain at least one hydrophobic fluorochrome A (acceptor) and at least one hydrophobic fluorochrome D (donor), A being different from D and the emission of fluorochrome D allowing light radiation to excite fluorochrome A.
- encapsulated is meant the fact that fluorochromes are almost absent from the surface of the particles. They are mainly concentrated within the polymer particles so as to leave the external surface thereof available.
- the fluorochromes according to the invention are selected so as to cover the four major areas of the light spectrum, namely blue (400-500 nm), green (500-550 nm), yellow (550-600 nm) and red (600-750 n).
- fluorochromes are chemically and photochemically stable.
- DPA diphenyl-anthracene
- 10 BPEA 9, 10 bis-phenyl-ethynyl-anthracene
- 1, 8 dichloro 9 10 bis-phenyl-ethynyl-anthracene
- 10 BPEA 5- 12 bis-phenyl-ethynyl-naphthacene
- 5, 12 BPEN 6
- 13-bis (phenylethynyl) pentacene tetrabenzo ( de, hi, op, st) pentacene
- Coumarin 153 Nile Red
- the pairs of fluorochromes or the trios as will be seen hereinafter in a variant of the invention are chosen according to the purpose and the conditions of use of the latex particles.
- the phenomenon of electronic energy transfer involves a donor D *, a molecule brought to a state excited by any form of radiation and an acceptor An molecule with a fundamental state.
- the energy initially acquired by the donor can be transmitted to the molecule A to form the excited species A *, without there being direct excitation of Ao-
- the acceptor can then transmit in place of the donor, at its own wavelength ⁇ (A).
- the normal donor emission (D * ⁇ D + hv) is replaced by:
- the latex particles containing said fluorochromes conventionally consist of polymers obtained by polymerization of ethylenically unsaturated monomers. It is a homopolymer or copolymer containing units derived from vinyl aromatic, ethylenic monomers, optionally functionalized alkanoic or ethylenic acids or esters.
- polystyrene resin is easily accessible to any person skilled in the art and we will be content to cite a few of them below, without implied limitation. It can be: - ethylenic monomers of isoprene type, 1, 3 butadiene, vinylidene chloride, acrylonitrile,
- - vinyl aromatic monomers such as styrene, bromostyrene, alphamethylstyrene, ethylstyrene, vinyltoluene, chlorostyrene or chloromethylstyrene or vinylnaphthalene, - alkanoic acids, esters or anhydrides such as acrylic, methacrylic, acrylates and methacrylates in which the alkyl group has 3 to 10 carbon atoms, hydroxyalkylacrylates, acrylamides, esters of ethylenic acids with 4 or 5 carbon atoms as well as, - difunctional monomers such as divinylbenzene or 2,2-dimethyl diacrylate -1.3-propylene and / or other copolymerizable monomers insoluble in water.
- the monomers can carry anionic or cationic groups of the sulfate, sulfonate, phosphonate or quaternary ammonium type. They may also be groups capable of reacting, directly or indirectly, with functional groups of the amino type, for example, carried by biological molecules such as proteins and enzymes. Mention may be made, as representative of these functional groups, of halogens, carboxyl groups, amines, isocyanates, aziridines, aldehydes, sulfonyls and epoxy, chloromethyl functions.
- the monomers, more particularly used in the context of the present invention belong to the family of arylenes and / or alkylenees.
- vinyl aromatic compounds such as: styrene, alphamethylstyrene, ethylstyrene, tert-butylstyrene and vinyltoluene.
- these monomers are substituted by one or more functional groups of halogen, amino, alkoxy, carboxyl and / or sulfonyl type.
- the polymer particles can be obtained by the use of any polymerization technique such as conventional emulsion polymerization, microemulsion, suspension, microsuspension, or if necessary by polymerization in organic medium. These techniques familiar to those skilled in the art will not be recalled here.
- the particles containing the fluorescent latex according to the invention are hydrophobic and preferably have a size generally between 0.01 and 20 microns and preferably less than 5 microns. They are calibrated, monodispersed and present in the latex in an amount varying between 0.05 to 10% by weight of the total weight of the latex, preferably between 0.1 and 1%.
- the fluorescent latex is characterized in that the emission of fluorochrome D directly makes it possible to excite fluorochrome A, the emission spectrum of fluorochrome D partially covering the excitation spectrum of fluorochrome A.
- the molar ratios A: D is for at least 10%, preferably at least 50%, by weight of the particles greater than 1, advantageously greater than 1.2.
- the A / D ratio is greater than 1, preferably greater than 1.2. Surprisingly, it has in fact been found that the latex particles having such a ratio lead to an amplification phenomenon of the intensity of the emission signal.
- the fluorescent latex is characterized in that the emission of fluorochrome D makes it possible to indirectly excite fluorochrome A, the particles of the latex containing at least one intermediate fluorochrome I whose excitation spectrum partially covers the spectrum emission spectrum and the emission spectrum overlaps partially the excitation spectrum of A.
- the molar ratio A: I and I: D will always be greater than 1, preferably ⁇ 1.2.
- the latex particles having such a ratio also lead to an amplification of the intensity of the emission signal.
- trio makes it possible to move the wavelength of emission of the latex even more and consequently therefore to avoid even more surely any interference and moreover avoids the overlapping of the emission spectra of A and of excitation. of D, which makes the quantification even more precise.
- the fluorescent latexes according to the invention can be used in all the applications of conventional latexes well known to those skilled in the art (paint, etc.).
- the fluorescent latexes according to the invention are more particularly intended to intervene directly or indirectly in biological analyzes. They can for example be used as reagents in immunological tests, scintillators, calibration standards in flow cytofluorometry for example or even as cellular markers. In the latter case, phagocytosis of the particles of a fluorescent latex is carried out by the cells to be studied.
- the subject of the invention is therefore the applications of fluorescent latexes in the biological field. These applications most often require the prior attachment of an immunoreactive species to the latex.
- the invention therefore relates to fluorescent latexes. functionalized with at least one immunoreactive species.
- the coupling of a fluorescent latex to an immunoreactive species is carried out via one or more functional group (s), reactive (s) and present (s) on the surface of these particles.
- the conventional procedure for carrying out this type of coupling involves the creation of a covalent bond with this immunoreactive species, by simple chemical reaction.
- the chemical groups present on the surface of the particles can either react directly with the immunoreactive compounds carrying free amine or sulfhydryl functions or, indirectly after activation.
- functional groups mention may in particular be made of carboxyl, haloalkyl, alkylsulfonyl and vinylsulfonyl groups. In the case of aldehyde and epoxy groups, the latter can be chemically activated beforehand to lead to a function having a higher activity vis-à-vis the immunoreactive species.
- immunoreactive species any chemical or biological compound carrying at least one site capable of complexing with another specific molecule called receptor.
- immunoreactive species mention may be made of primary amines, amino acids, peptides, proteins, lipoproteins or microorganisms of the virus or bacteria type for example. It can also be an antibody or an enzyme.
- the essential mission of this immunoreactive species is to react with another species, either by simple biological affinity or by chemical reaction, by complexing through one of its functions at a receptor site for the species to be assayed.
- Functionalized fluorescent latexes find application in the field of immunoassay.
- the latexes functionalized with a determined antibody are thus capable of recognizing the complementary antigens present in a biological fluid such as blood, urine.
- the diagnosis depends on the recognition or non-recognition of antigens. This result is quantifiable by the intensity of the signal which depends on the concentration of antigens.
- Fluorescent latexes also find application in cell labeling.
- an immunoreactive species grafted onto the fluorescent latex reacts with one or more surface antigens of a cell and makes it possible to detect its presence by fluorescence. Examples include the detection of cancer cells which cause, for example, the increase in the number of EGF receptors (Epidermal Growth Factor).
- the latexes according to the present invention also find an advantageous application in flow cytofluorometry which makes it possible to carry out quantitative measurements on a multiplicity of cells, but which are analyzed one by one. For each cell, it is possible to determine its volume, its size and in the presence of specific fluorescent markers, its DNA and RNA level as well as the presence of membrane antigens, or other receptors for example. Associated with this analytical capacity, the physical and selective separation of cell subpopulations according to parameters determined in advance by the user amplifies the interest of this technique.
- the invention also relates to a process for the preparation of the fluorescent latexes described above.
- the preparation process is characterized in that one and / or the other of the following steps is carried out:
- the two stages will be successively carried out when one of the two stages has not made it possible, taking into account the method chosen, to include the various fluorochromes in the latex particles.
- the various fluorochromes in the latex particles.
- the first step is usually called the overpolymerization step while the second is called the solvent swelling step.
- the fluorescent latex particles obtained at the end of one and / or the other of these two methods, are then characterized in terms of fluorochromic occupancy rate, residual fluorescence of the supernatant and detection sensitivity of fluorescence emission.
- the maximum occupancy rate of the latex particles in hydrophobic fluorochromes is of course depending on the nature of fluorochromes, the insertion technique implementation, the nature 'of the polymer constituting the particles and the size of these particles. This occupancy rate can therefore vary considerably and reach values of several million molecules of fluorochromes per particle of latex. As an indication, for a particle with a diameter of 0.3 ⁇ m, this rate varies from 10,000 to 400,000, preferably between 60,000 and 350,000, fluorochromic molecules per particle of latex.
- the fluorescent latexes which are the subject of examples below, have been characterized by their detection threshold in fluorescent emission and, their respective particles, by their level of occupation in fluorochromes according to the following methods:
- a - Measurement of the fluorescence detection threshold EUe consists in determining the minimum concentration of particles detectable by the fluorimeter under conditions acceptable in terms of signal / noise ratio (> 10), by a conventional fluorimeter and without deoxygenation of the medium.
- This conventional fluorometer includes a polychromatic light source (150 W xenon lamp), grating monochromators, a conventional detector and a device for reading and / or recording the induced photocurrent. It also does not include any specific signal processing device. It is clear that this minimum detectable concentration strongly depends on the analysis conditions. Consequently, the values indicated in the examples below, determined under standard conditions, should be considered as indicative of the minimum performance of the fluorescent latexes analyzed.
- This rate is accessible by dissolving a known weight of the dry sec- in a solvent common to the polymer and to the fluorochrome. In general, it is toluene.
- the fluorochrome concentration is then determined by UV-visible absorption.
- the particle concentration is deduced by calculation from the weight of dry polymer, the particle size and the density of the polymer.
- the occupancy rate ⁇ p is then given by the ratio:
- This fluorescent latex is prepared according to the swelling technique using the following reagents:
- the 9.10 DPA is dissolved in 7.5 g of toluene, then added with acetone (98 g).
- the pH of the latex is adjusted by NH 4 OH to a value of 10.
- the potassium laurate is then added to the latex and the whole is homogenized for a few minutes with stirring.
- the fluorochrome solution is then added slowly to the latex.
- the resulting suspension is stirred for 3 hours at 40 ° C.
- the organic solvents are then removed by distillation as slowly as possible. Deionized water is added during the distillation so as to adjust the dry extract to around 5%.
- the 9.10 BPEA is dissolved in the remaining toluene, then added with acetone (98g g).
- the pH of the latex is then readjusted by NH 4 OH to a value of 10.
- the fluorochrome solution is then added slowly to the latex.
- the resulting suspension is stirred for 3 hours at 40 ° C.
- the organic solvents are then removed as before.
- the final dry weight extract (ES) is close to 5%.
- the fluorescent latex thus obtained is washed by ultrafiltration.
- the latex obtained has the following characteristics:
- BPEA acceptor 123,000 labels / particle, ie 0.3% polymer weight. Insertion yield: 100%. The acceptor / donor labeling ratio is 1.5.
- the photoinduced fluorescence was then measured using the experimental device comprising a polychromatic light source (150 W Xenon lamp), grating monochromators, a conventional detector and a device for reading and / or recording the signal.
- a polychromatic light source 150 W Xenon lamp
- grating monochromators grating monochromators
- a conventional detector a device for reading and / or recording the signal.
- Excited at 360 nm area where the absorption of 9.10 DPA is 8 times greater than that of 9.10 BPEA
- the emission spectrum of the latex is practically reduced on the emission of 9.10 BPEA (Max: 480 and 510 nm).
- the emission of 9.10 DPA Max 410 and 430 nm
- the excitation was recorded for the emission at 550 nm (where the fluorescence of 9.10 DPA is negligible).
- the spectrum shows distinct shoulders corresponding to the peaks characteristic of the excitation of 9.10 DPA.
- an energy transfer from 9.10 DPA to 9.10 BPEA must result in a significant increase in the ratios I (360) / I (440) and I (375) / I (440).
- the fluorescence detection threshold of the sample is equal to 5.10-15 moles of particles per liter.
- the fluorescent latex is prepared according to Example 1 using the following reagents: Latex according to Example 1 1.8 C1 2 -9.10 BPEA 0.028 g
- the latex obtained has the following characteristics: 1.8 Cl 2 -9, 10 BPEA 77,000 labels / particle or 0.29% of the weight of the polymer 5.12-BPEN 88,000 labels / particle or 0.32% of the weight of the polymer polymer.
- the acceptor / donor labeling ratio is 1.15.
- the ratio of the intensity emitted at 620 nm (emission of the BPEN) is then encrypted for excitations at:
- the limit of detection was then measured, which is 6-10-15 M of particles / L.
- the fluorescence equivalent to a particle of latex is 158,000 molecules of 5,12-BPEN, or almost twice the actual labeling of the latex in 5,12 BPEN.
- the fluorescent latex is prepared according to Example 1 using the following reagents:
- Latex according to Example 1 9.10 BPEA 0.028 g
- the latex obtained has the following characteristics: 9.10 BPEA 105,000 labels / particle or 0.34% of the weight of the polymer 1.8 Cl 2 -9.10 BPEA 107,000 labels / particle or 0.40% of the weight of the polymer .
- the acceptor / donor labeling ratio is 1.02. Under excitation at 400 nm (where the light is practically absorbed by 9.10 BPEA) the emission is practically reduced to 1.8 Cl 2 -9, 10 BPEA
- the limit of detection was then measured, which is 2-10-15 M of particles / L for an excitation at 470 nm and an emission at 530 nm. Consequently, the fluorescence equivalent to a latex particle is 211,000 molecules of 1.8 Cl -9.10 BPEA, ie twice the actual labeling of the latex with 1.8 Cl 2 -9.10 BPEA.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Luminescent Compositions (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69403663T DE69403663T2 (de) | 1993-07-12 | 1994-07-11 | Fluoreszenzlatex, enthaltend mindestens zwei fluorochrome, herstellungsverfahren und anwendung |
CA002167072A CA2167072C (fr) | 1993-07-12 | 1994-07-11 | Latex fluorescent comportant au moins deux fluorochromes, procede d'obtention et application |
JP7504377A JPH09504041A (ja) | 1993-07-12 | 1994-07-11 | 少なくとも二つの蛍光色素を含む蛍光ラテックス、その製法と応用 |
EP94922905A EP0712426B1 (fr) | 1993-07-12 | 1994-07-11 | Latex fluorescent comportant au moins deux fluorochromes, procede d'obtention et application |
US08/586,673 US5716855A (en) | 1993-07-12 | 1994-11-07 | Fluorescent latex containing at least two fluorochromes, process for producing it and application thereof |
NO960123A NO308253B1 (no) | 1993-07-12 | 1996-01-11 | Fluorescerende lateks inneholdende to fluorkrom, fremgangsmÕte for fremstilling av den og anvendelse av denne |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9308573A FR2707658B1 (fr) | 1993-07-12 | 1993-07-12 | Latex fluorescent comportant au moins deux fluorochromes, procédé d'obtention et application dudit latex comme marqueur, notamment en biologie. |
FR93/08573 | 1993-07-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995002635A1 true WO1995002635A1 (fr) | 1995-01-26 |
Family
ID=9449186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1994/000867 WO1995002635A1 (fr) | 1993-07-12 | 1994-07-11 | Latex fluorescent comportant au moins deux fluorochromes, procede d'obtention et application |
Country Status (10)
Country | Link |
---|---|
US (1) | US5716855A (fr) |
EP (1) | EP0712426B1 (fr) |
JP (1) | JPH09504041A (fr) |
CA (1) | CA2167072C (fr) |
DE (1) | DE69403663T2 (fr) |
DK (1) | DK0712426T3 (fr) |
ES (1) | ES2104405T3 (fr) |
FR (1) | FR2707658B1 (fr) |
NO (1) | NO308253B1 (fr) |
WO (1) | WO1995002635A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9227181B2 (en) | 2011-09-13 | 2016-01-05 | Basf Corporation | Catalyst to increase propylene yields from a fluid catalytic cracking unit |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578498A (en) | 1991-05-22 | 1996-11-26 | Behringwerke Ag | Metal chelate containing compositions for use in chemiluminescent assays |
US6251581B1 (en) | 1991-05-22 | 2001-06-26 | Dade Behring Marburg Gmbh | Assay method utilizing induced luminescence |
US6238931B1 (en) * | 1993-09-24 | 2001-05-29 | Biosite Diagnostics, Inc. | Fluorescence energy transfer in particles |
GB9602265D0 (en) * | 1996-02-05 | 1996-04-03 | Amersham Int Plc | Benzophenoxazine dyes |
JP3338616B2 (ja) * | 1996-09-05 | 2002-10-28 | 富士通株式会社 | 蛍光体層の形成方法及び蛍光体ペースト |
AU1080999A (en) * | 1997-10-14 | 1999-05-03 | Luminex Corporation | Precision fluorescently dyed particles and methods of making and using same |
WO1999042838A1 (fr) | 1998-02-18 | 1999-08-26 | Dade Behring Inc. | Compositions chimioluminescentes servant a detecter des substances multiples a analyser |
CA2342767C (fr) * | 1998-09-03 | 2009-11-03 | Trellis Bioinformatics, Inc. | Etiquettes a nuances multiples |
US6642062B2 (en) | 1998-09-03 | 2003-11-04 | Trellis Bioinformatics, Inc. | Multihued labels |
US6703248B1 (en) * | 1999-12-15 | 2004-03-09 | Dade Behring Marburg Gmbh | Particles for diagnostic and therapeutic use |
US20050164261A1 (en) * | 2001-10-09 | 2005-07-28 | Chandler Don J. | Multiplexed analysis of clinical specimens apparatus and methods |
US8148171B2 (en) | 2001-10-09 | 2012-04-03 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and methods |
US20070128732A1 (en) * | 2003-07-02 | 2007-06-07 | Lucille Beaudet | Scintillator composition for a radioassay, and method for its use |
US7407816B2 (en) * | 2004-05-07 | 2008-08-05 | Gentius, Inc | Isoelectric particles and uses thereof |
CN101019028B (zh) * | 2004-09-10 | 2013-05-01 | 皇家飞利浦电子股份有限公司 | 用于组合的光学-超声成像的化合物和方法 |
US7507588B2 (en) * | 2005-04-20 | 2009-03-24 | Becton, Dickinson And Company | Multiplex microparticle system |
US7939613B2 (en) * | 2005-04-22 | 2011-05-10 | The Hong Kong University Of Science And Technology | Fluorescent water-soluble conjugated polyene compounds that exhibit aggregation induced emission and methods of making and using same |
NO20053373D0 (no) * | 2005-07-11 | 2005-07-11 | Rikshospitalet Radiumhospitale | Multicolored Particles. |
JP2012517486A (ja) | 2009-02-09 | 2012-08-02 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 電気泳動ディスプレイのための着色粒子 |
EP2393851B1 (fr) | 2009-02-09 | 2018-02-28 | Merck Patent GmbH | Particules pour écrans électrophorétiques |
KR20110116214A (ko) | 2009-02-09 | 2011-10-25 | 메르크 파텐트 게엠베하 | 전기영동 디스플레이용 착색 입자 |
KR101796796B1 (ko) | 2009-02-09 | 2017-11-10 | 메르크 파텐트 게엠베하 | 전기영동 디스플레이용 착색 입자 |
GB2475226A (en) * | 2009-11-03 | 2011-05-18 | Genetic Analysis As | Universal Prokaryote 16S ribosome PCR primer pair |
GB201021399D0 (en) | 2010-12-16 | 2011-01-26 | Genetic Analysis As | Oligonucleotide probe set and methods of microbiota profiling |
GB201021397D0 (en) | 2010-12-16 | 2011-01-26 | Genetic Analysis As | Diagnosis of Crohn's disease |
GB201102693D0 (en) | 2011-02-16 | 2011-03-30 | Genetic Analysis As | Method for identifying neonates at risk for necrotizing enterocolitis |
WO2014166583A1 (fr) | 2013-04-12 | 2014-10-16 | Merck Patent Gmbh | Particules pour écrans électrophorétiques |
CN107108818B (zh) | 2014-12-19 | 2021-01-01 | 默克专利股份有限公司 | 用于电泳显示器的颗粒 |
KR20190042641A (ko) * | 2016-08-31 | 2019-04-24 | 세키스이가가쿠 고교가부시키가이샤 | 진단약용 형광 입자 및 그것을 사용한 면역 측정 시약 |
CN111363539A (zh) * | 2020-04-30 | 2020-07-03 | 上海思滤科技有限公司 | 一种单分散多色发光微球及其制备方法与应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0280556A2 (fr) * | 1987-02-27 | 1988-08-31 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Particule insoluble dans l'eau et réactif immunoréactif, éléments analytiques et méthodes pour leur utilisation |
WO1991010893A1 (fr) * | 1990-01-16 | 1991-07-25 | Caribbean Microparticles Corporation | Norme de reference pour microperles de cytometre et procede de reglage d'un cytometre a ecoulement au moyen de ces microperles en vue d'obtenir des resultats reproductibles |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3000483A1 (de) * | 1979-01-09 | 1980-07-17 | Fuji Photo Film Co Ltd | Mikrokapseln fuer immunologische bestimmungen |
US5607864A (en) * | 1992-04-07 | 1997-03-04 | Societe Prolabo | Fluorescent latices having very low detection thresholds for fluorescent emission |
US5264960A (en) * | 1992-05-08 | 1993-11-23 | At&T Bell Laboratories | Optical wavelength shifter |
US5369036A (en) * | 1992-07-02 | 1994-11-29 | Becton, Dickinson And Company | Enhancement of signal in immunoassays using microparticles which contain different detectable substances |
US5393527A (en) * | 1993-01-04 | 1995-02-28 | Becton, Dickinson And Company | Stabilized microspheres and methods of preparation |
-
1993
- 1993-07-12 FR FR9308573A patent/FR2707658B1/fr not_active Expired - Fee Related
-
1994
- 1994-07-11 DK DK94922905.8T patent/DK0712426T3/da active
- 1994-07-11 WO PCT/FR1994/000867 patent/WO1995002635A1/fr active IP Right Grant
- 1994-07-11 JP JP7504377A patent/JPH09504041A/ja active Pending
- 1994-07-11 DE DE69403663T patent/DE69403663T2/de not_active Expired - Lifetime
- 1994-07-11 CA CA002167072A patent/CA2167072C/fr not_active Expired - Lifetime
- 1994-07-11 EP EP94922905A patent/EP0712426B1/fr not_active Expired - Lifetime
- 1994-07-11 ES ES94922905T patent/ES2104405T3/es not_active Expired - Lifetime
- 1994-11-07 US US08/586,673 patent/US5716855A/en not_active Expired - Lifetime
-
1996
- 1996-01-11 NO NO960123A patent/NO308253B1/no not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0280556A2 (fr) * | 1987-02-27 | 1988-08-31 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Particule insoluble dans l'eau et réactif immunoréactif, éléments analytiques et méthodes pour leur utilisation |
WO1991010893A1 (fr) * | 1990-01-16 | 1991-07-25 | Caribbean Microparticles Corporation | Norme de reference pour microperles de cytometre et procede de reglage d'un cytometre a ecoulement au moyen de ces microperles en vue d'obtenir des resultats reproductibles |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9227181B2 (en) | 2011-09-13 | 2016-01-05 | Basf Corporation | Catalyst to increase propylene yields from a fluid catalytic cracking unit |
Also Published As
Publication number | Publication date |
---|---|
ES2104405T3 (es) | 1997-10-01 |
US5716855A (en) | 1998-02-10 |
CA2167072A1 (fr) | 1995-01-26 |
EP0712426B1 (fr) | 1997-06-04 |
EP0712426A1 (fr) | 1996-05-22 |
DE69403663D1 (de) | 1997-07-10 |
JPH09504041A (ja) | 1997-04-22 |
FR2707658A1 (fr) | 1995-01-20 |
DE69403663T2 (de) | 1998-01-02 |
DK0712426T3 (da) | 1997-12-22 |
CA2167072C (fr) | 2008-10-28 |
FR2707658B1 (fr) | 1995-11-24 |
NO960123D0 (no) | 1996-01-11 |
NO308253B1 (no) | 2000-08-21 |
NO960123L (no) | 1996-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0712426B1 (fr) | Latex fluorescent comportant au moins deux fluorochromes, procede d'obtention et application | |
JP5400297B2 (ja) | 蛍光ナノシリカ粒子、ナノ蛍光材料、それを用いたバイオチップ及びそのアッセイ法 | |
EP0539477B1 (fr) | Procede d'amplification du signal d'emission d'un compose luminescent | |
EP1966260B1 (fr) | Procede de preparation de particules composites, particules composites obtenues et leur utilisation dans un test diagnostic | |
JP5213296B2 (ja) | 発光性ミクロ粒子およびナノ粒子の製造および使用 | |
US5607864A (en) | Fluorescent latices having very low detection thresholds for fluorescent emission | |
US20100240115A1 (en) | Bioanalytical assay | |
WO1990005307A1 (fr) | Methode d'agglutination pour l'analyse d'une substance | |
KR20130091644A (ko) | 감도가 증가된 균질 화학발광 검정 방법 | |
JPH06217795A (ja) | 電子移動剤を含む組成物、試験デバイス及び方法 | |
EP1690091A1 (fr) | Nouvelles sondes hybrides a luminescence exaltee | |
EP3129783B1 (fr) | Utilisation de particules absorbantes pour améliorer la détection du signal dans un procédé d'analyse | |
CN101044403A (zh) | 改变微球表面特性的方法 | |
WO1992001224A1 (fr) | Procede de reduction d'interferences dans un dosage par fluorescence | |
EP3129784B1 (fr) | Utilisation d'un colorant pour améliorer la détection du signal dans un procédé d'analyse | |
EP3126832A1 (fr) | Contrôles pour la mise en oeuvre de procédés d'analyse multiplexe | |
CN101788482B (zh) | 一种用于识别和检测萘酚异构体的试剂混合液及其制备方法 | |
FR2615621A1 (fr) | Composes et procedes permettant une agglutination reversible, et kits analytiques contenant lesdits composes | |
FR2689516A1 (fr) | Latex fluorescent possédant un seuil de détection en émission fluorescente très faible. | |
FR2585836A1 (fr) | Procede homogene de detection et/ou de determination par luminescence d'un analyte dans un milieu susceptible de le contenir | |
FR2663337A1 (fr) | Particules polymeres, comportant une couche de surface contenant des groupements reactifs aldehydes aromatiques, permettant de fixer par covalence des ligands biologiques amines, leur preparation et leur utilisation. | |
JP4355190B2 (ja) | 生物学的被検体の高速検出方法 | |
EP0623822B1 (fr) | Réactifs indicateurs pour la détection ou le dosage d'un analyte, trousses les contenant, et procédé de détection ou de dosage | |
FR2841156A1 (fr) | Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenant | |
FR2691546A1 (fr) | Traceurs particulaires directs, utilisation pour la mesure et le dosage d'anticorps et d'antigène. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP NO US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1994922905 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2167072 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08586673 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1994922905 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1994922905 Country of ref document: EP |